| For: | Alenzi M, Almeqdadi M. Bridging the gap: Addressing disparities in hepatitis C screening, access to care, and treatment outcomes. World J Hepatol 2024; 16(8): 1091-1098 [PMID: 39221096 DOI: 10.4254/wjh.v16.i8.1091] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v16/i8/1091.htm |
| Number | Citing Articles |
| 1 |
Gianluca Azzellino, Lia Ginaldi, Massimo De Martinis. A Biosocial Roadmap to Tackle the Burden of Hepatitis C Virus Infections That Ensures Health Equity for All. Clinical Infectious Diseases 2025; 81(1) doi: 10.1093/cid/ciae623
|
| 2 |
Vitória Machado Krüger, Ana Carolina Almeida da Silva, Marlise Antunes Grahl, Matheus dos Anjos Catasblancas, Maiara Lenise Lütz, João Pedro Stepan Wagner, Alexandre Lemos da Silva, Eduardo Viegas da Silva, Pedro Augusto Crespo da Silva. Factors influencing hepatitis C treatment initiation in a high-prevalence Brazilian state. Cadernos de Saúde Pública 2026; 42 doi: 10.1590/0102-311xen233025
|
| 3 |
Pietro Torre, Mariano Festa, Tommaso Sarcina, Mario Masarone, Marcello Persico. Elimination of HCV Infection: Recent Epidemiological Findings, Barriers, and Strategies for the Coming Years. Viruses 2024; 16(11) doi: 10.3390/v16111792
|
| 4 |
Jean Wignall, Wendy Bennett, Lily P. H. Yang, Phyu Sin Aye, Clair Shiuan Miao, Catherine Jackson, Karen Bartholomew, Joanna Hikaka, Edward J. Gane, Felicity Goodyear-Smith. Demographic profile of potential target populations in community laboratory and emergency department settings for consideration in expanding hepatitis C screening in Aotearoa New Zealand. The Journal of Primary Health Care 2026; doi: 10.1071/HC26042
|
| 5 |
Dana Ivancovsky Wajcman, Aina Nicolàs, Camila A. Picchio, Lena van Selm, Geoffrey Dusheiko, Zobair M. Younossi, John F. Dillon, Saleh A. Alqahtani, Homie Razavi, Massimo G. Colombo, Achim Kautz, Gregory J. Dore, Jeffrey V. Lazarus. Prioritising viral hepatitis elimination to prevent hepatocellular carcinoma: A public health approach for effective preventive hepatology. JHEP Reports 2025; 7(8) doi: 10.1016/j.jhepr.2025.101436
|
| 6 |
Chansovannara Soputhy, Florian Girond, Samley Keo, Kolveasna Kim, Luis Sagaon-Teyssier, Capucine Penicaud, Sovann Ly, Emilie Mosnier. Early performance of a decentralised, primary-care hepatitis C programme in Cambodia: a retrospective programme evaluation, 2024. The Lancet Regional Health - Western Pacific 2025; 65 doi: 10.1016/j.lanwpc.2025.101758
|
| 7 |
Zoi Papalamprakopoulou, Melissa B. Scribani, Nicole L. Krupa, Paul L. Jenkins, Jennifer M. Victory, Arpan Dharia, Wendy M. Brunner, Daniel A. Freilich, Andrew H. Talal. Hepatitis C care cascade using direct-acting antivirals in rural new York State from 2013 to 2023: a retrospective observational study. BMC Infectious Diseases 2026; 26(1) doi: 10.1186/s12879-026-13539-5
|
| 8 |
Jacob Mugoya Gizamba, Darren Ruddell, Jeffrey D Klausner. Spatial disparities in access to Hepatitis C treatment providers in Los Angeles County: An enhanced two-step floating catchment area analysis. Spatial and Spatio-temporal Epidemiology 2026; 57 doi: 10.1016/j.sste.2026.100809
|
| 9 |
Aisha Elsharkawy, Rasha Eletreby. Direct-Acting Antivirals against Hepatitis C. 2026; doi: 10.1016/B978-0-443-41363-6.00007-X
|
| 10 |
Gia Landry, Mark Sulkowski, Jordan J. Feld, Nancy Reau, Stacey Scherbakovsky, Farrah Black, Candido Hernández, Renee-Claude Mercier, Liyun Ni, Marc Bourlière, Alessandra Mangia. Predictive Value of Sustained Virologic Response at Week 4 in Patients with Hepatitis C Virus Infection Treated with Sofosbuvir/Velpatasvir. Viruses 2026; 18(2) doi: 10.3390/v18020269
|
| 11 |
Helen Jarvis, Paul N Brennan, Teresa Casanovas, Kelly Casler, Monica Desai, Philip H Evans, John F Dillon, Ignazio Grattagliano, Kate Hallsworth, Vanessa Hebditch, Sema Mandal, Alisa E Pedrana, Jen-Kuei Peng, Andrew D Schreiner, Abdel-Aziz Shaheen, Maja Thiele, Patricia C Valery, Julia Verne, Shlomo Vinker, David Whiteley, Martin C S Wong, Shira Zelber-Sagi. The role of primary care in response to the global liver disease syndemic: a Lancet Gastroenterology & Hepatology Commission. The Lancet Gastroenterology & Hepatology 2026; doi: 10.1016/S2468-1253(26)00015-4
|
| 12 |
Chieu‐Hoang Ly Luong, Lisa Kalisch Ellett, Nicole Pratt, Kirsten Staff, Jack Janetzki. Trends in Use of Direct‐Acting Antivirals for Treatment of Hepatitis C Virus Infection in Australia 2016–2024. Journal of Viral Hepatitis 2025; 32(10) doi: 10.1111/jvh.70082
|
| 13 |
Rohan Karkra, Mahinaz Mohsen, Sameer Rao, Kaveh Hajifathalian, Ahmed Al‐Khazraji. Rising Incidence of Acute Hepatitis C in the United States: A 15‐Year Analysis of Racial, Ethnic and Sex Disparities. Liver International Communications 2026; 7(2) doi: 10.1002/lci2.70051
|
| 14 |
Omega Mathew Immanuel, Olaoluwa Tolulope Fabiyi, Kuat P. Oshakbayev, Gulzhan Abuova, Aliya Konysbekova, Sreenu B. Vattipally, Syed Ali, Syed Hani Abidi. A Bibliometric Analysis of the HCV Drug-Resistant Majority and Minority Variants. International Journal of Environmental Research and Public Health 2025; 22(11) doi: 10.3390/ijerph22111670
|
| 15 |
Jean-Michel Pawlotsky. Hepatitis C virus elimination: So close, so far?. Antiviral Research 2026; 247 doi: 10.1016/j.antiviral.2026.106360
|
| 16 |
Chrissy P.B. Moonen, Elfi E.H.G. Brouwers, Casper D.J. den Heijer, Nicole H.T.M. Dukers-Muijrers, Jill Buursma, Inge H.M. van Loo, Christian J.P.A. Hoebe. Integrating hepatitis and HIV point-of-care testing into mandatory migrant tuberculosis screening in the Netherlands: A feasibility and acceptability study. Public Health in Practice 2025; 10 doi: 10.1016/j.puhip.2025.100671
|